2,3-Dihydro-2-[(3-exo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl]-1H-benz[e]isoindol-1-one


Phase change data

Go To: Top, References, Notes

Data compilation copyright by the U.S. Secretary of Commerce on behalf of the U.S.A. All rights reserved.

Data compiled by: William E. Acree, Jr., James S. Chickos

Enthalpy of fusion

ΔfusH (kcal/mol) Temperature (K) Method Reference
6.96448.2DSCCappelli, Travagli, et al., 2006

References

Go To: Top, Phase change data, Notes

Data compilation copyright by the U.S. Secretary of Commerce on behalf of the U.S.A. All rights reserved.

Cappelli, Travagli, et al., 2006
Cappelli, Andrea; Travagli, Valter; Zanardi, Iacopo; Anzini, Maurizio; Giorgi, Gianluca; Donati, Alessandro; Aggravi, Marianna; Casolaro, Mario; Fresta, Massimo; Paccagnini, Eugenio; Makovec, Francesco; Vomero, Salvatore, Physicochemical and biopharmaceutical characterization ofendo-2-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-1H-benz[e]isoindol-1-one (CR3124) a novel potent 5-HT3 receptor antagonist, J. Pharm. Sci., 2006, 95, 12, 2706-2721, https://doi.org/10.1002/jps.20705 . [all data]


Notes

Go To: Top, Phase change data, References